Top Section/Ad
Top Section/Ad
Most recent
Military goggles maker Theon starts €150m rights issue
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
European equity capital markets remain muted ahead of what many participants expect to be an extremely busy autumn window. Yet in London, there is one live deal of substantial size progressing steadily towards completion.
-
Shares in Melrose Industries, the UK investment firm, began trading ex-rights on Tuesday ahead of its £1.6bn ($2.08bn) rights issue on the London Stock Exchange.
-
The share price of Melrose, the UK industrial buyouts specialist, leapt as much as 16% on Monday after the company said the window shop period of its acquisition of Nortek had expired, allowing the deal and Melrose’s jumbo £1.6bn rights issue to proceed. -
Ascendis Health, the South African manufacturer of diet supplements, garden pesticides and medical equipment, has raised R1.2bn ($83m) through an oversubscribed rights issue that will enable it to complete two European acquisitions.
-
Hong Kong-listed United Energy Group is planning a rights issue of at least 13.08bn shares to raise a potential HK$2.6bn ($335.2m), according to a filing.
-
The key to the clean-up and recapitalization of Italy’s Banca Monte dei Paschi di Siena is a €5bn rights issue but even though a strong cast of top tier ECM banks have signed on to run it, the deal still hinges on finding real demand. Aidan Gregory and Owen Sanderson report.
